Virumbrales-Muñoz, María
Ayuso, Jose M.
Lacueva, Alodia
Randelovic, Teodora
Livingston, Megan K.
Beebe, David J.
Oliván, Sara
Pereboom, Desirée
Doblare, Manuel
Fernández, Luis
Ochoa, Ignacio
Article History
Received: 25 June 2018
Accepted: 3 April 2019
First Online: 17 April 2019
Change Date: 15 January 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing Interests
: I. Ochoa and L.J. Fernandez are both promoters and consultants for BeOnChip S.L. and EBERS Medical Technology S.L. (Zaragoza, Spain). David J. Beebe holds equity in Bellbrook Labs, LLC, Tasso Inc., SalusDiscovery LLC, Lynx Biosciences, Inc., Stacks to the Future, LLC, TurbaLLC, and Onexio Biosystems, LLC. Cited companies have had no role in the decision to publish nor was involved in the experiments or writing of this manuscript. M.V., J.A., A.L., T.R., M.K.L, S.O., D.P. and M.D. have no conflict of interest.